Search clinical trials for: Everolimus and tacrolimus

Total 271195 results

Astellas Pharma Inc

Completed

A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

Rheumatoid Arthritis

Japan
The Second Artillery General Hospital
Capital Medical University; Shanghai Changzheng Hospital; Air Force General Hospital... and other collaborators

Completed

Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation (PSIDRTG)

Renal Transplantation

China
Astellas Pharma Inc

Completed

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation

Liver Transplantation

China
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant

Heart Transplant Failure and Rejection

United States
LEO Pharma

Completed

Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

Healthy

Germany
Linical Korea
National Cancer Center, Korea; Astellas Pharma Korea, Inc.

Completed

To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients (Assign)

Liver Transplantation
Rennes University Hospital

Completed

Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells (DIFF-TAC)

Hemochromatosis

France
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter

Cirrhosis, Liver

China
Astellas Pharma Inc

Completed

Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Japan
Assaf-Harofeh Medical Center

Unknown

Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study

Allergic Conjunctivitis

Israel
Hospices Civils de Lyon

Unknown

EVESOR: a Phase 1 Trial of Everolimus and Sorafenib (EVESOR)

Metastatic or Locally Advanced Solid Tumors

France
Mayo Clinic
National Cancer Institute (NCI)

Completed

Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Spanish Society of Cardiology

Unknown

Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques

Coronary Artery Disease

Spain
Astellas Pharma China, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Liver Transplantation | Kidney Transplantation

China
Astellas Pharma China, Inc.

Completed

A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Liver Transplantation | Kidney Transplantation

China
Hanlim Pharm. Co., Ltd.

Unknown

The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus

Healthy Male Volunteers

Korea, Republic of
Auritec Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study

Psoriasis | Organ Transplant Rejection

United States
Astellas Pharma Inc

Completed

Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation (OPTIMIZE)

Kidney Transplantation

Taiwan, Korea, Republic of
Astellas Pharma Europe Ltd.

Completed

A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation (OPTION)

Liver Transplantation | Kidney Transplantation | Heart Transplantation

Belgium, France, Germany, Poland, Spain, United Kingdom
Kim, Seoung-Hoon
Astellas Pharma Korea, Inc.; Linical Korea

Completed

To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

Liver Transplantation
Astellas Pharma Inc

Completed

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Italy
Astellas Pharma Inc

Completed

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts (PANTERA)

LIVER TRANSPLANTATION

Italy
Astellas Pharma Inc

Completed

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Myasthenia Gravis

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.

Liver Transplantation

France, Italy, Poland, Belgium, Spain, Germany, Switzerland, Canada, Finland, Brazil, Czech Republic, Australia, Norway, Sweden, United Kingdom, Ireland
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

Asthma, Bronchial | Bronchial Asthma

Russian Federation, Hungary, Germany, Poland, Bulgaria, Ukraine, Czech Republic
Meril Life Sciences Pvt. Ltd.

Unknown

BioMime Vs. Xience Randomised Control Clinical Study (meriT-V)

Coronary Artery Disease

United Kingdom, Brazil, Spain, Macedonia, The Former Yugoslav Republic of, Belgium, Czechia, Latvia, Netherlands, Poland
Novartis Pharmaceuticals

Withdrawn

Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients. (Prometheus)

Liver Transplantation
Poitiers University Hospital

Completed

Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

Chronic Kidney Disease

France
Haukeland University Hospital
Ullevaal University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark and other collaborators

Completed

Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)

Neuroendocrine Carcinoma

Norway
San Giuseppe Moscati Hospital

Completed

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

ST Elevation Acute Myocardial Infarction

Italy
Emory University
Novartis

Completed

Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

Thyroid Cancer

United States
Mayo Clinic
Veloxis Pharmaceuticals

Active, not recruiting

Envarsus XR Compared to Immediate Release Tacrolimus (SIMPLE)

Kidney Transplant Recipients

United States
Georgetown University

Terminated

Envarsus XR in African American Renal Transplant Recipients (EXR)

Renal Transplant Recipients

United States
University of Illinois at Chicago
Astellas Pharma US, Inc.

Completed

A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients (Tacrolimus ER)

Kidney Transplantation

United States
Astellas Pharma Inc

Completed

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

Dermatitis, Atopic

United Kingdom, Finland, Ireland, Canada, Latvia
Barbara Ann Karmanos Cancer Institute

Completed

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

Hematological Malignancies

United States
Astellas Pharma Inc

Completed

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

Kidney Transplantation

United States, Canada
Beijing Tsinghua Chang Gung Hospital

Not yet recruiting

Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.

Liver Transplantation
Astellas Pharma Inc
Astellas Pharma China, Inc.

Completed

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

Myasthenia Gravis

China
Astellas Pharma Inc

Completed

Distribution of Tacrolimus in Skin, Atopic Dermatitis

Dermatitis, Atopic

Ireland
Astellas Pharma Inc

Completed

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

Dermatitis, Atopic

United Kingdom, Finland, Ireland, Canada, Latvia
Eisai Inc.
Merck Sharp & Dohme LLC

Completed

A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

Non Clear Cell Renal Cell Carcinoma (nccRCC)

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Melanoma (Skin)

United States
Astellas Pharma Inc

Completed

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

Liver Transplantation

United States
RenJi Hospital

Not yet recruiting

Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients

Liver Transplant

China
University of Wisconsin, Madison
Veloxis Pharmaceuticals

Recruiting

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

Kidney Pancreas Transplantation

United States
Sandoz

Withdrawn

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. (TODAY)

Kidney Transplant

France, Germany
UMC Utrecht

Completed

Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients

Atopic Dermatitis

Netherlands
Université Catholique de Louvain

Unknown

Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism (CYRANO)

Kidney Diseases

Belgium
Astellas Pharma Inc

Completed

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Dermatitis, Atopic

Poland, Czech Republic, Hungary

3

Subscribe